Skip to main content

Pallister-Killian Syndrome

<p>Pallister-Killian syndrome is a rare genetic disorder characterized by weak muscle tone, distinct facial features, intellectual impairment, developmental delays, and other systemic involvement.</p>

Alumni Notes, Fall 2023

Dec 5, 2023

The CHOP Alumni Organization created a new recognition, the Patrick Pasquariello Service Award. See who was honored with the inaugural award.

News at CHOP: Fall 2023

Dec 5, 2023

Stay up to date on the latest research and staff news from Children’s Hospital of Philadelphia.

FDA Approves Two Gene Therapies for Sickle Cell Disease

Dec 8, 2023

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Jump back to top